ENSG

The Ensign Group Inc
NASDAQHEALTHCAREMEDICAL CARE FACILITIES

Key Statistics

Market Cap
$10.21B
P/E Ratio
27.46
EPS
$6.38
Beta
0.69
52W High
$217.84
52W Low
$141.52
50-Day MA
$176.36
200-Day MA
$181.83
Dividend Yield
0.15%
Profit Margin
6.90%
Forward P/E
20.70
PEG Ratio
1.38

About The Ensign Group Inc

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$5.49B
Gross Profit (TTM)$908.93M
EBITDA$582.74M
Operating Margin9.04%
Return on Equity17.00%
Return on Assets5.49%
Revenue/Share (TTM)$95.13
Book Value$42.26
Price-to-Book4.17
Price-to-Sales (TTM)1.86
EV/Revenue2.21
EV/EBITDA19.51
Quarterly Earnings Growth (YoY)16.70%
Quarterly Revenue Growth (YoY)17.30%
Shares Outstanding$58.28M
Float$55.65M
% Insiders3.53%
% Institutions92.56%

Historical Volatility

HV 10-Day
22.19%
HV 20-Day
16.41%
HV 30-Day
18.46%
HV 60-Day
21.35%
HV Rank
22.2%

Volatility is currently expanding

Analyst Ratings

Consensus ($220.00 target)
1
Strong Buy
3
Buy
1
Hold

Latest News

ROSEN, REGARDED INVESTOR COUNSEL, Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG

New York, New York--(Newsfile Corp. - September 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Ensign securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Newsfile Corp9/24/2026Neutral
Ensign Investor News: If You Have Suffered Losses in Excess of $100K in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.

GlobeNewsWire9/22/2026Neutral
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0650 Per Share

SAN JUAN CAPISTRANO, Calif., Sept. 18, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it has declared a quarterly cash dividend of $0.0650 per share of Ensign common stock, payable on or before October 31, 2026, to shareholders of record as of September 30, 2026.

GlobeNewsWire9/18/2026Neutral
Ensign Investor News: If You Have Suffered Losses in Excess of $100K in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Sept. 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.

GlobeNewsWire9/16/2026Neutral
Kaplan Fox Encourages Investors of The Ensign Group, Inc. (ENSG) to Learn More About the Firm's Investigation

New York, New York--(Newsfile Corp. - September 14, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. ("Ensign" or the "Company") (NASDAQ: ENSG). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Ensign investor and have suffered losses, or if you have information that could assist in the Ensign investigation, you may CLICK HERE to contact us.

Newsfile Corp9/14/2026Neutral
Ensign Group (ENSG) Upgraded to Buy: Here's Why

Ensign Group (ENSG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research9/14/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ENSG and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 9/26/2026